Caribou Biosciences, Inc. financial data

Symbol
CRBU on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2929 7 Th Street, Suite 105, Berkeley, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.12K % +23.5%
Debt-to-equity 17.5 % -30.8%
Return On Equity -34.8 % +8.36%
Return On Assets -29.6 % +2.28%
Operating Margin -428 % +49.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.4M shares +2.35%
Common Stock, Shares, Outstanding 90.4M shares +36.7%
Entity Public Float 263M USD -14.6%
Common Stock, Value, Issued 9K USD +50%
Weighted Average Number of Shares Outstanding, Basic 90.3M shares +47.1%
Weighted Average Number of Shares Outstanding, Diluted 90.3M shares +47.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.1M USD +132%
Research and Development Expense 129M USD +31.8%
General and Administrative Expense 45.6M USD +21.8%
Operating Income (Loss) -142M USD -16.9%
Nonoperating Income (Expense) 18.3M USD +83.9%
Income Tax Expense (Benefit) 193K USD +176%
Net Income (Loss) Attributable to Parent -123M USD -11%
Earnings Per Share, Basic -1.32 USD/shares +27.5%
Earnings Per Share, Diluted -1.32 USD/shares +27.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.9M USD -42.8%
Marketable Securities, Current 228M USD
Cash, Cash Equivalents, and Short-term Investments 312M USD +6.6%
Accounts Receivable, after Allowance for Credit Loss, Current 215K USD -71.9%
Assets, Current 271M USD +0.87%
Property, Plant and Equipment, Net 19.9M USD +28.8%
Operating Lease, Right-of-Use Asset 21.1M USD -8.93%
Other Assets, Noncurrent 1.64M USD +15.3%
Assets 373M USD +6.66%
Accounts Payable, Current 3.23M USD -27.2%
Employee-related Liabilities, Current 6.49M USD +28.9%
Accrued Liabilities, Current 23.6M USD +48.6%
Contract with Customer, Liability, Current 2.83M USD -78.2%
Liabilities, Current 30.9M USD -9.98%
Contract with Customer, Liability, Noncurrent 4.6M USD -74.7%
Deferred Income Tax Liabilities, Net 557K USD +46.6%
Operating Lease, Liability, Noncurrent 25.5M USD -2.4%
Liabilities 62.5M USD -22.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -319K USD +71.9%
Retained Earnings (Accumulated Deficit) -378M USD -48.4%
Stockholders' Equity Attributable to Parent 310M USD +15.2%
Liabilities and Equity 373M USD +6.66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.2M USD -33.2%
Net Cash Provided by (Used in) Financing Activities 12.5M USD +660%
Net Cash Provided by (Used in) Investing Activities 23M USD +10.9%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 90.4M shares +36.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.76M USD +68.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.9M USD -42.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 96.2M USD +44.8%
Deferred Tax Assets, Gross 105M USD +36.4%
Operating Lease, Liability 26.8M USD -1.63%
Payments to Acquire Property, Plant, and Equipment 1.45M USD -28.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -123M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 39.9M USD -8.1%
Property, Plant and Equipment, Gross 30.5M USD +37.2%
Operating Lease, Liability, Current 1.26M USD +17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72M USD +27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.48M USD +17.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.1M USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.92M USD +3.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.09M USD +46.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.12M USD +3.38%
Operating Lease, Payments 711K USD -35%
Additional Paid in Capital 689M USD +31.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 710K USD +20.5%
Deferred Tax Assets, Net of Valuation Allowance 8.76M USD -16.6%
Share-based Payment Arrangement, Expense 15.8M USD +26.2%
Interest Expense 4K USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%